RecruitingNot ApplicableNCT06801691

The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe


Sponsor

EUthyroid

Enrollment

4,500 participants

Start Date

Dec 30, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

In the EUthyroid2 intervention, measures are being developed and implemented in educational settings across the UK, Germany, Slovenia, the Republic of Cyprus, Bangladesh, and Pakistan to effectively raise awareness of the risks associated with iodine deficiency. Each participating country will employ three measurement points. The intervention will be tailored to the specific contextual characteristics of each implementation site. A process evaluation utilizing a convergent parallel mixed methods design will be conducted, involving surveys of students and teachers, as well as semi-structured interviews.


Eligibility

Min Age: 13 YearsMax Age: 17 Years

Inclusion Criteria1

  • sufficient language skills to understand the study information, informed consent

Exclusion Criteria1

  • none

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExperimental: Intervention group

Educational materials: Iodine Feedback Tool, lecture on the topic of iodine and health, booklet, exercises, group assignments and a webpage This is a pre/post intervention with no control group.


Locations(6)

Bangladesh University of Health

Dhaka, Bangladesh

Cyprus University of Technology

Limassol, Cyprus

University Medicine Greifswald

Greifswald, Germany

Islamia College Peshawar

Peshawar, Khyber Pakhtunkhwa, Pakistan

University Medical Centre Ljubljana

Ljubljana, Slovenia

University of Surrey; Queen's University Belfast

Guildford, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06801691


Related Trials